[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Primary Cells Market Research Report by Origin (Animal Primary Cells and Human Primary Cells), by Cell Type (Dermatocytes, Gastrointestinal Cells, Heart Cells, Hematopoietic Cells, and Hepatocytes), by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19

February 2021 | 187 pages | ID: PE6772BA0825EN
360iResearch

US$ 3,949.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Primary Cells Market is expected to grow from USD 1,025.78 Million in 2020 to USD 1,733.95 Million by the end of 2025.
2. The Global Primary Cells Market is expected to grow from EUR 899.42 Million in 2020 to EUR 1,520.36 Million by the end of 2025.
3. The Global Primary Cells Market is expected to grow from GBP 799.59 Million in 2020 to GBP 1,351.60 Million by the end of 2025.
4. The Global Primary Cells Market is expected to grow from JPY 109,476.92 Million in 2020 to JPY 185,056.78 Million by the end of 2025.
5. The Global Primary Cells Market is expected to grow from AUD 1,489.57 Million in 2020 to AUD 2,517.93 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Primary Cells to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Origin, the Primary Cells Market studied across Animal Primary Cells and Human Primary Cells.

Based on Cell Type, the Primary Cells Market studied across Dermatocytes, Gastrointestinal Cells, Heart Cells, Hematopoietic Cells, Hepatocytes, Lung Cells, Musculoskeletal Cells, and Renal Cells. The Hepatocytes further studied across Cryopreserved Hepatocytes and Fresh Hepatocytes.

Based on End-user, the Primary Cells Market studied across Life Science Companies and Research Institutes.

Based on Geography, the Primary Cells Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Primary Cells Market including AcceGen, Allcells, American Type Culture Collection, Axol Bioscience Ltd., BioIVT, Biopredic International, BPS Bioscience, Inc., Cell Biologics, Inc., Corning Incorporated, Creative Bioarray, Epithelix S?RL, Ixcells Biotechnologies, Lonza Group AG, Merck KGaA, Neuromics, Ppa Research Group, Inc., Promocell GmbH, Reachbio LLC, Sciencell Research Laboratories, Inc., Sekisui Xenotech, LLC, Stem Cell Technologies, Inc., StemExpress, LLC, Thermo Fisher Scientific, Inc., and Zenbio, Inc..

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Primary Cells Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Primary Cells Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Primary Cells Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Primary Cells Market?
4. What is the competitive strategic window for opportunities in the Global Primary Cells Market?
5. What are the technology trends and regulatory frameworks in the Global Primary Cells Market?
6. What are the modes and strategic moves considered suitable for entering the Global Primary Cells Market?
1. PREFACE

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Define: Research Objective
  2.1.2. Determine: Research Design
  2.1.3. Prepare: Research Instrument
  2.1.4. Collect: Data Source
  2.1.5. Analyze: Data Interpretation
  2.1.6. Formulate: Data Verification
  2.1.7. Publish: Research Report
  2.1.8. Repeat: Report Update
2.2. Research Execution
  2.2.1. Initiation: Research Process
  2.2.2. Planning: Develop Research Plan
  2.2.3. Execution: Conduct Research
  2.2.4. Verification: Finding & Analysis
  2.2.5. Publication: Research Report
2.3. Research Outcome

3. EXECUTIVE SUMMARY

3.1. Introduction
3.2. Market Outlook
3.3. Origin Outlook
3.4. Cell Type Outlook
3.5. End-user Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. MARKET OVERVIEW

4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. MARKET INSIGHTS

5.1. Market Dynamics
  5.1.1. Drivers
    5.1.1.1. Growing acceptance in drug screening and cell based assays
    5.1.1.2. Advantages of primary human cells over other existing methods
    5.1.1.3. Growing focus on monoclonal antibodies and personalized medicine
  5.1.2. Restraints
    5.1.2.1. Common cell culture problems such as contamination
  5.1.3. Opportunities
    5.1.3.1. Expanding biotechnology and biopharmaceutical industries
    5.1.3.2. Government as well as private investment in cell-based research
    5.1.3.3. Advancements in biomedical research using primary cells
  5.1.4. Challenges
    5.1.4.1. Ethical issues in cell biology research field
5.2. Porters Five Forces Analysis
  5.2.1. Threat of New Entrants
  5.2.2. Threat of Substitutes
  5.2.3. Bargaining Power of Customers
  5.2.4. Bargaining Power of Suppliers
  5.2.5. Industry Rivalry

6. GLOBAL PRIMARY CELLS MARKET, BY ORIGIN

6.1. Introduction
6.2. Animal Primary Cells
6.3. Human Primary Cells

7. GLOBAL PRIMARY CELLS MARKET, BY CELL TYPE

7.1. Introduction
7.2. Dermatocytes
7.3. Gastrointestinal Cells
7.4. Heart Cells
7.5. Hematopoietic Cells
7.6. Hepatocytes
  7.6.1. Cryopreserved Hepatocytes
  7.6.2. Fresh Hepatocytes
7.7. Lung Cells
7.8. Musculoskeletal Cells
7.9. Renal Cells

8. GLOBAL PRIMARY CELLS MARKET, BY END-USER

8.1. Introduction
8.2. Life Science Companies
8.3. Research Institutes

9. AMERICAS PRIMARY CELLS MARKET

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. ASIA-PACIFIC PRIMARY CELLS MARKET

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET

11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. COMPETITIVE LANDSCAPE

12.1. FPNV Positioning Matrix
  12.1.1. Quadrants
  12.1.2. Business Strategy
  12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
  12.5.1. Merger & Acquisition
  12.5.2. Agreement, Collaboration, & Partnership
  12.5.3. New Product Launch & Enhancement
  12.5.4. Investment & Funding
  12.5.5. Award, Recognition, & Expansion

13. COMPANY USABILITY PROFILES

13.1. AcceGen
13.2. Allcells
13.3. American Type Culture Collection
13.4. Axol Bioscience Ltd.
13.5. BioIVT
13.6. Biopredic International
13.7. BPS Bioscience, Inc.
13.8. Cell Biologics, Inc.
13.9. Corning Incorporated
13.10. Creative Bioarray
13.11. Epithelix S?RL
13.12. Ixcells Biotechnologies
13.13. Lonza Group AG
13.14. Merck KGaA
13.15. Neuromics
13.16. Ppa Research Group, Inc.
13.17. Promocell GmbH
13.18. Reachbio LLC
13.19. Sciencell Research Laboratories, Inc.
13.20. Sekisui Xenotech, LLC
13.21. Stem Cell Technologies, Inc.
13.22. StemExpress, LLC
13.23. Thermo Fisher Scientific, Inc.
13.24. Zenbio, Inc.

14. APPENDIX

14.1. Discussion Guide
14.2. License & Pricing

LIST OF TABLES

TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PRIMARY CELLS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEART CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ARGENTINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. BRAZIL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. BRAZIL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. BRAZIL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. CANADA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. CANADA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CANADA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. MEXICO PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. MEXICO PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. MEXICO PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED STATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED STATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. UNITED STATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. CHINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. CHINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. CHINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. INDIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. INDIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. INDIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDONESIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDONESIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDONESIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. JAPAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. JAPAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. JAPAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. MALAYSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. MALAYSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. MALAYSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. THAILAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. THAILAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. THAILAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. FRANCE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. FRANCE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. FRANCE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. GERMANY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. GERMANY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. GERMANY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. ITALY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. ITALY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. ITALY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. QATAR PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. QATAR PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. QATAR PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. RUSSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. RUSSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. RUSSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SPAIN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SPAIN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SPAIN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. GLOBAL PRIMARY CELLS MARKET: SCORES
TABLE 109. GLOBAL PRIMARY CELLS MARKET: BUSINESS STRATEGY
TABLE 110. GLOBAL PRIMARY CELLS MARKET: PRODUCT SATISFACTION
TABLE 111. GLOBAL PRIMARY CELLS MARKET: RANKING
TABLE 112. GLOBAL PRIMARY CELLS MARKET: MERGER & ACQUISITION
TABLE 113. GLOBAL PRIMARY CELLS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 114. GLOBAL PRIMARY CELLS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 115. GLOBAL PRIMARY CELLS MARKET: INVESTMENT & FUNDING
TABLE 116. GLOBAL PRIMARY CELLS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 117. GLOBAL PRIMARY CELLS MARKET: LICENSE & PRICING


LIST OF FIGURES

FIGURE 1. GLOBAL PRIMARY CELLS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PRIMARY CELLS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PRIMARY CELLS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2020 (USD MILLION)
FIGURE 5. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 7. GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL PRIMARY CELLS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL PRIMARY CELLS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL PRIMARY CELLS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2020 VS 2025 (%)
FIGURE 15. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2025
FIGURE 17. GLOBAL PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2020 VS 2025 (%)
FIGURE 20. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2025
FIGURE 22. GLOBAL PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEART CELLS, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 33. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2025
FIGURE 35. GLOBAL PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, 2020 VS 2025 (USD MILLION)
FIGURE 37. AMERICAS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 38. AMERICAS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 40. ARGENTINA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. BRAZIL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. CANADA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. MEXICO PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. UNITED STATES PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 46. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 48. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. CHINA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. INDIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. INDONESIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. JAPAN PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. MALAYSIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. THAILAND PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 60. FRANCE PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. GERMANY PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. ITALY PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 63. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. QATAR PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. RUSSIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. SPAIN PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. GLOBAL PRIMARY CELLS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 72. GLOBAL PRIMARY CELLS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 73. GLOBAL PRIMARY CELLS MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PRIMARY CELLS MARKET, BY TYPE


More Publications